Kabata Tamon, Matsumoto Tadami, Yagishita Shinichi, Wakayama Tomohiko, Iseki Shoichi, Tomita Katsuro
Department of Orthopaedic Surgery, Kanazawa University School of Medicine, Kanazawa, Japan.
J Rheumatol. 2008 Dec;35(12):2383-90. doi: 10.3899/jrheum.070838. Epub 2008 Nov 1.
Vascular endothelial growth factor (VEGF) is an angiogenic promoter that is rapidly induced as a response to local hypoxia. We investigated VEGF expression in rabbits in a controlled experiment to clarify the onset of ischemic events in corticosteroid-induced osteonecrosis (ON).
Ninety-nine mature Japanese white rabbits were divided into 6 treatment groups and an untreated control group. The treatment groups received a single intramuscular injection of 4 mg/kg methylprednisolone acetate; they were euthanized at different times, and tissue samples were obtained from their femora. We examined the development of ON and the expression of VEGF using histopathology, immunohistochemistry, Northern blot analysis, and Western blot analysis.
On histopathological examination, the earliest indication of ON was 5 days after the corticosteroid treatment. The frequency of ON occurrence reached a plateau at or after Week 1. VEGF expression was accompanied by the development of ON. VEGF-positive cells detected by immunohistochemistry were found among bone marrow cells, frequently located in the area surrounding ON, suggesting that VEGF production was switched on as a result of the ischemic events that cause ON. The level of VEGF-mRNA expression indicated by Northern blot analysis peaked at 3 days after the corticosteroid treatment and decreased gradually to the levels present in the control group at 7 days after treatment. Western blot analysis revealed VEGF protein production at 3 days after the corticosteroid treatments. Levels of VEGF expression 2 weeks or more after the corticosteroid treatment were almost the same as in the control group.
We observed early expression of VEGF in the cells around the corticosteroid-induced ON lesions in rabbits. These results suggest that the ischemic events that cause ON begin soon after the initial corticosteroid treatment.
血管内皮生长因子(VEGF)是一种血管生成促进因子,可作为对局部缺氧的反应而迅速被诱导产生。我们在一项对照实验中研究了兔体内VEGF的表达情况,以阐明皮质类固醇诱导性骨坏死(ON)中缺血事件的发生情况。
将99只成年日本白兔分为6个治疗组和1个未治疗的对照组。治疗组接受一次4mg/kg醋酸甲泼尼龙的肌肉注射;在不同时间对它们实施安乐死,并从其股骨获取组织样本。我们使用组织病理学、免疫组织化学、Northern印迹分析和Western印迹分析来检查ON的发展情况以及VEGF的表达。
组织病理学检查显示,ON最早在皮质类固醇治疗后5天出现。ON的发生率在第1周或之后达到平台期。VEGF的表达与ON的发展相伴。免疫组织化学检测到的VEGF阳性细胞存在于骨髓细胞中,常位于ON周围区域,这表明VEGF的产生是由导致ON的缺血事件开启的。Northern印迹分析显示的VEGF - mRNA表达水平在皮质类固醇治疗后3天达到峰值,并在治疗后7天逐渐降至对照组的水平。Western印迹分析显示皮质类固醇治疗后3天有VEGF蛋白产生。皮质类固醇治疗2周或更长时间后的VEGF表达水平与对照组几乎相同。
我们观察到兔体内皮质类固醇诱导性ON病变周围细胞中VEGF的早期表达。这些结果表明,导致ON的缺血事件在最初的皮质类固醇治疗后不久就开始了。